Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clioquinol versus metronidazole for Dientamoeba fragilis infection in children
NL-OMON39247Active, not recruiting
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Clioquinol and metronidazole in dientamoebiasis (2 arms), sponsored by Medisch Centrum Leeuwarden. Primary endpoint: Difference in efficacy of clioquinol versus metronidazole. Started Oct 2010; status: active, not recruiting.
02
Drugs
Clioquinolmetronidazole
03
Conditions
dientamoebiasis
Beyond the preview
Go deeper on NL-OMON39247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39247.